← Leaderboards
Andy Agrawal
Respana Therapeutics, Inc.
$598,498
Attributed
$598,498
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2018–22$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$598,498 · 2
By mechanism
R41$598,498 · 2
Top collaborators
No co-investigators on record.
Most similar at Respana Therapeutics, Inc.
Same institution · by research overlap
- Timothy J Pelura$1,000,000
Others in their field
Other Emerging Leaders on “Fighting”
- Prasant Mohapatra · University Of California At Davis$45,797,125
- Jeffrey Reich · Sparian Biosciences, Inc.$13,729,307
- Angela Ramona Branche · University Of Rochester$10,119,005
- Nikej Shah · Nirsum Laboratories, Inc.$7,640,042
- Thomas Dick · Rbhs-New Jersey Medical School$6,021,400
- Carlos Castro-Gonzalez · Leuko Labs, Inc.$5,762,701
Research focus
FightingHost DefenseCellsDrug KineticsHistopathologyHospitalizationBaseBody WeightCombatCytokineAcuteHealthcare SystemsAlveolar MacrophagesAnimalsBacterial PneumoniaAntibodiesBiological AvailabilityBiological ModelsCessation Of LifeCo-InfectionAntiviral AgentsCommercializationAttenuatedImmune